Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2018-05-14 M&A Activity
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
关于并购基金的投资进展公告
M&A Activity Classification · 95% confidence The document is a detailed announcement from 九芝堂股份有限公司 about the progress of an investment made by a merger and acquisition (M&A) fund into a company called Stemedica Cell Technologies, Inc. It includes extensive information about the fund's establishment, the investment agreement, the target company, its shareholders, financials, management, and the strategic rationale and risks of the investment. The document is not a full annual or quarterly report, nor is it a simple announcement of voting results or a regulatory filing. It is focused on the progress and details of an M&A-related investment transaction. Therefore, the document fits best into the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids, including investment progress in acquisition funds.
2018-05-14 Chinese
中信证券股份有限公司关于公司发行股份购买资产暨关联交易之持续督导意见书（2017年度）
Audit Report / Information Classification · 95% confidence The document is titled as a "持续督导意见书" (Continuous Supervision Opinion Letter) issued by CITIC Securities as an independent financial advisor regarding a major asset restructuring transaction involving Jiuzhitang Co., Ltd. It discusses the delivery and transfer of assets, fulfillment of commitments, performance of profit forecasts, management discussion and analysis, and corporate governance structure post-transaction. The document includes detailed financial and operational information related to the asset purchase and related party transactions, as well as compliance with regulatory requirements. It is not a full annual or interim report, nor is it a simple announcement or certification. It is a specialized supervisory opinion report related to a major asset restructuring and related party transaction, which fits best under the category of Audit Report / Information (AR), as it includes audit opinions, compliance with regulations, and detailed financial advisory content related to the transaction. The document length (7293 characters) and content confirm it is a substantive report rather than a brief announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2017
2018-05-03 Chinese
大股东减持股份计划实施进展公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the progress of a major shareholder's share reduction plan. It details the shareholder's holdings before and after the reduction, the number of shares reduced, the reduction period, and compliance with regulations. There is no financial statement or comprehensive report content, but rather a disclosure of shareholding changes by a significant shareholder. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document length is short and focused solely on shareholding changes, not a full financial or management report.
2018-04-26 Chinese
2018年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "九芝堂股份有限公司 2018 年第一季度报告全文" which translates to "Jiuzhitang Co., Ltd. 2018 First Quarter Report Full Text." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2018. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2018
2018-04-26 Chinese
2018年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 年第一季度报告正文" which translates to "2018 First Quarter Report". It contains detailed financial data including revenue, net profit, cash flow, and other financial metrics for the first quarter of 2018. It also includes shareholder information, changes in financial indicators, and notes on important events during the quarter. The length of the document (6754 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive quarterly financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2018
2018-04-26 Chinese
中信证券股份有限公司关于公司利用闲置自有资金进行投资理财的核查意见
Capital/Financing Update Classification · 95% confidence The document is a formal opinion from an independent financial advisor (CITIC Securities) regarding the company's plan to use idle funds for investment purposes. It details the investment purpose, types, risk analysis, control measures, and approval procedures. The document is not a financial report, earnings release, or regulatory filing of financial results. It is a specific advisory opinion related to a financing or capital use decision, focusing on the company's use of idle funds for investment. This fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage plans. The document length is 2546 characters, which is too short to be a full report but contains substantive content about capital use, not just an announcement or certification. Therefore, the classification is CAP with high confidence.
2018-04-19 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.